Arrowstreet Capital’s Diebold Nixdorf DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$39.8M Sell
468,040
-51,161
-10% -$4.11M 0.02% 643
2026
Q1
$39.2M Buy
519,201
+88,534
+21% +$6.51M 0.02% 564
2025
Q4
$29.2M Buy
430,667
+28,064
+7% +$1.75M 0.02% 634
2025
Q3
$23M Buy
402,603
+330,526
+459% +$19.6M 0.01% 683
2025
Q2
$3.99M Buy
+72,077
New +$3.38M ﹤0.01% 1245
2024
Q2
Sell
-33,058
Closed -$1.14M 1567
2024
Q1
$1.14M Buy
+33,058
New +$1.06M ﹤0.01% 1297

Other funds holding DBD

Arrowstreet Capital's DBD Position: Q2 2026 in Review

Arrowstreet Capital reduced its Diebold Nixdorf (DBD) stake by 9.9% in Q2 2026, selling an estimated $4.11M and leaving 468,040 shares worth $39.8M. The position accounts for 0.02% of the portfolio, ranked #643.

Arrowstreet Capital first reported a position in DBD in Q1 2024 and has held it in 6 quarters since. 216 funds tracked by Wall St. Rank hold DBD as of Q2 2026.

  • Arrowstreet Capital held 468,040 shares of Diebold Nixdorf worth $39.8M as of Q2 2026.
  • Arrowstreet Capital sold 51,161 Diebold Nixdorf shares in Q2 2026, an estimated $4.11M.
  • Diebold Nixdorf made up 0.02% of Arrowstreet Capital's portfolio in Q2 2026, its #643 holding.
  • Arrowstreet Capital first reported a position in Diebold Nixdorf in Q1 2024 and has held it in 6 quarters since.
  • 216 funds tracked by Wall St. Rank held Diebold Nixdorf as of Q2 2026.

Based on Arrowstreet Capital's 13F filing for Q2 2026, filed 13 Aug 2026.